NDC 50222-501

TACLONEX

Calcipotriene And Betamethasone Dipropionate

TACLONEX is a Topical Suspension in the Human Prescription Drug category. It is labeled and distributed by Leo Pharma Inc.. The primary component is Calcipotriene Hydrate; Betamethasone Dipropionate.

Product ID50222-501_32213990-fc7f-49a5-a8c9-65833aeb3edd
NDC50222-501
Product TypeHuman Prescription Drug
Proprietary NameTACLONEX
Generic NameCalcipotriene And Betamethasone Dipropionate
Dosage FormSuspension
Route of AdministrationTOPICAL
Marketing Start Date2008-06-01
Marketing CategoryNDA / NDA
Application NumberNDA022185
Labeler NameLEO Pharma Inc.
Substance NameCALCIPOTRIENE HYDRATE; BETAMETHASONE DIPROPIONATE
Active Ingredient Strength50 ug/g; mg/g
Pharm ClassesVitamin D [CS],Vitamin D Analog [EPC],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 50222-501-06

40 CARTON in 1 CASE (50222-501-06) > 1 BOTTLE in 1 CARTON > 60 g in 1 BOTTLE
Marketing Start Date2008-06-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 50222-501-06 [50222050106]

TACLONEX SUSPENSION
Marketing CategoryNDA
Application NumberNDA022185
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2008-06-01

NDC 50222-501-51 [50222050151]

TACLONEX SUSPENSION
Marketing CategoryNDA
Application NumberNDA022185
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2008-06-01

NDC 50222-501-66 [50222050166]

TACLONEX SUSPENSION
Marketing CategoryNDA
Application NumberNDA022185
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2008-06-01

NDC 50222-501-03 [50222050103]

TACLONEX SUSPENSION
Marketing CategoryNDA
Application NumberNDA022185
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2010-11-09
Marketing End Date2012-11-06

NDC 50222-501-52 [50222050152]

TACLONEX SUSPENSION
Marketing CategoryNDA
Application NumberNDA022185
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2008-06-01
Marketing End Date2012-07-30

Drug Details

Active Ingredients

IngredientStrength
CALCIPOTRIENE HYDRATE50 ug/g

OpenFDA Data

SPL SET ID:757c914f-dd8d-43cc-a973-212d591af4af
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 833463
  • 833461

    • Pharmacological Class

    • Vitamin D [CS]
    • Vitamin D Analog [EPC]
    • Corticosteroid [EPC]
    • Corticosteroid Hormone Receptor Agonists [MoA]

    Medicade Reported Pricing

    50222050166 TACLONEX 0.005%-0.064% SUSPENSION

    Pricing Unit: GM | Drug Type:

    50222050106 TACLONEX 0.005%-0.064% SUSPENSION

    Pricing Unit: GM | Drug Type:

    NDC Crossover Matching brand name "TACLONEX" or generic name "Calcipotriene And Betamethasone Dipropionate"

    NDCBrand NameGeneric Name
    50222-227Taclonexcalcipotriene and betamethasone dipropionate
    50222-501TACLONEXcalcipotriene and betamethasone dipropionate
    0781-7165CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATEcalcipotriene and betamethasone dipropionate
    45802-889calcipotriene and betamethasone dipropionatecalcipotriene and betamethasone dipropionate
    45802-989Calcipotriene and Betamethasone Dipropionatecalcipotriene and betamethasone dipropionate
    51672-1402Calcipotriene and Betamethasone DipropionateCalcipotriene and Betamethasone Dipropionate
    63629-8618calcipotriene and betamethasone dipropionatecalcipotriene and betamethasone dipropionate
    63629-8619calcipotriene and betamethasone dipropionatecalcipotriene and betamethasone dipropionate
    63646-040calcipotriene and betamethasone dipropionatecalcipotriene and betamethasone dipropionate
    66993-937Calcipotriene and Betamethasone DipropionateCalcipotriene and Betamethasone Dipropionate
    66993-938Calcipotriene and Betamethasone DipropionateCalcipotriene and Betamethasone Dipropionate
    50222-302ENSTILARcalcipotriene and betamethasone dipropionate
    73499-001WynzoraCalcipotriene and Betamethasone dipropionate

    Trademark Results [TACLONEX]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    TACLONEX
    TACLONEX
    76527083 3022407 Live/Registered
    LEO Pharma A/S
    2003-07-01
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.